EMR/EHR

Electronic medical records (EMR) are a digital version of a patient’s chart that store their personal information, medical history and links to prior exams, texts and reports. The goal of these systems is to enable immediate access to the patient's data electronically, rather than needing to request paper file folders that might be stored in fragment files at numerous locations where a patient is seen or treated. EMRs (also called electronic health records, or EHR) improve clinician and health system efficiency by making all this data immediately available. This helps reduce repeat tests, repeat prescriptions and repeat imaging exams because reports, imaging or other patient data is not not immediately available. 

RSS icon

CHIME responds to MU announcement

CHIME President and CEO Russell Branzell has issued a response to the news from Centers for Medicare & Medicaid Services Acting Administrator Andy Slavitt that the Meaningful Use (MU) program will come to an end this year.

Thumbnail

Slavitt: CMS moving away from MU

With technology in virtually every place that care is provided, the Centers for Medicare & Medicaid Services (CMS) is in the process of ending Meaningful Use and moving to "a new regime culminating with [the Medicare Access & CHIP Reauthorization Act of 2015 (MACRA)]," said Andy Slavitt, CMS acting director, speaking at the 34th Annual J.P. Morgan Healthcare Conference in San Francisco.

AMA launches Silicon Valley company to grow innovation footprint

The American Medical Association (AMA) has announced a $15 million investment to become founding partner of a healthcare innovation company, called Health2047, that will conduct rapid exploration of innovative solutions to the biggest challenges facing the nation’s 1.1 million physicians and the patients they serve.

Thumbnail

Nearly 1 in 3 patients say email communication with providers improved their health

According to a new survey published in the American Journal of Managed Care, nearly one-third of patients who sent electronic messages said it improved their health, and more than one-third said it led to less office phone calls and in-person visits.

Survey finds lack of patient access to online records

Despite the increase in EHR adoption, more than half of patients cannot access their full health records electronically, according to a HealthMine survey.

Stage 3 comments: ACP says 'recast MU under MIPS'

Meaningful Use is a significant component of the Merit-Based Incentive Payment System (MIPS) but both will fail without substantial changes, according to the American College of Physicians in its comments to the Centers for Medicare & Medicaid Services about the MU Stage 3 final rule.

Indiana hospitals achieve Stage 7

HIMSS Analytics has awarded three hospitals of the Munster, Ind.-based Community Healthcare System with Stage 7 of its EMR Adoption Model. 

Thumbnail

Despite need for HIT, few are 'champions'

Few healthcare providers are experienced with information mobility--the ability to seamlessly capture, manage and transform information regardless its format, where it comes from or where it needs to go—even though that is probably the path to success with federal initiatives including Meaningful Use and accountable care.

Displaying 249 - 256 of 484

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup